Confusion over whether CBD should be considered a narcotic drug has developed into a major question mark over the substance’s future in Europe.
Based on a plain reading of the 1961 Single Convention on Narcotic Drugs (1961 Convention), the European Commission (EC) considers CBD that is extracted from a cannabis plant a narcotic, and therefore its Directorate-General for Health (DG Santé) has placed a hold on novel food applications for non-synthetic CBD products until a final decision is made.
Sign up to our platform and you will have access to our latest business and regulatory news analysis, which keeps you updated with the latest hot topics in the sector.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
